Evidence map›Paper›PMID 27590102›Full record

GuidelineBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2017

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Research Methodology and Study Design Working Group Report.

Bronwen E Shaw, Theresa Hahn, Paul J Martin, Sandra A Mitchell, Effie W Petersdorf, Gregory T Armstrong, Nonniekaye Shelburne, Barry E Storer, Smita Bhatia

Registry-linked trialAbstract readPractice GuidelineReview
PubMed Full text at PMC Publisher
In one paragraph

Guideline in Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07579065 (Survivorship Care in Patients With Hematologic Cancer Undergoing HSCT), which is not on this map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07579065 narecruitingnot on this mapstarted 2026, after this paper: background citation

Survivorship Care in Patients With Hematologic Cancer Undergoing HSCT: A Feasibility Study on Quality of Life, Unmet Needs, and Caregivers Burden

TypeinterventionalSponsorAzienda USL Reggio Emilia - IRCCSRan2026 to 2028Enrolled40ConditionsHematologic Neoplasm, Hematopoietic Stem Cell Transplantation, Survivorship, Cancer SurvivorshipArmsSurvivorship Care (SC) Plan
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Long-term complications after hematopoietic cell transplantation.Hematology/oncology and stem cell therapy · 2017
    Review
  10. Article
  11. Review
  12. Long-Term Survivorship after Hematopoietic Cell Transplantation: Roadmap for Research and Care.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2017
    Review
  13. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Developing Recommendations to Improve Survivorship and Long-Term Outcomes.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bronwen E ShawDepartment of Medicine, Medical College of Wisconsin, Center for International Blood and Marrow Transplant Research, Milwaukee, Wisconsin.
Theresa HahnDepartment of Medicine, Roswell Park Cancer Institute, Buffalo, New York.
Paul J MartinDepartment of Medicine, Division of Clinical Research, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington.
Sandra A MitchellOutcomes Research Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Rockville, Maryland.
Effie W PetersdorfDepartment of Medicine, Division of Clinical Research, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington.
Gregory T ArmstrongEpidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.
Nonniekaye ShelburneDivision of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland.
Barry E StorerDepartment of Medicine, Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Smita BhatiaInstitute for Cancer Outcomes and Survivorship, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama. Electronic address: sbhatia@peds.uab.edu.

Funding

Data Resource for Analyzing Blood &Marrow TransplantsU24CA076518 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Amy M Moskop, Bronwen Shaw · 1998 to 2026
$105.2M
BONE MARROW TRANSPLANT (BMT) SURVIVORS STUDYR01CA078938 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI BHATIA, SMITA · 2000 to 2003
$1.6M
NCI NIH HHS R01 CA078938NCI NIH HHS U24 CA076518
6 · The paper itself

Abstract

The increasing numbers of hematopoietic cell transplantations (HCTs) performed each year, the changing demographics of HCT recipients, the introduction of new transplantation strategies, incremental improvement in survival, and the growing population of HCT survivors demand a comprehensive approach to examining the health and well-being of patients throughout life after HCT. This report summarizes strategies for the conduct of research on late effects after transplantation, including consideration of the study design and analytic approaches; methodologic challenges in handling complex phenotype data; an appreciation of the changing trends in the practice of transplantation; and the availability of biospecimens to support laboratory-based research. It is hoped that these concepts will promote continued research and facilitate the development of new approaches to address fundamental questions in transplantation outcomes.

Indexed as

Hematopoietic Stem Cell TransplantationAdultDelivery of Health CareHealth Planning GuidelinesHumansLong Term Adverse EffectsMiddle AgedNational Institutes of Health (U.S.)Research DesignTime FactorsUnited StatesYoung AdultHematopoietic cell transplantationLate effectsNational Institutes of Health consensus

Identifiers

PMID27590102
PMCPMC5182148

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.